Dr. Ofer Levy was born to and raised by the artist Benjamin Levy and music composer Hannah Levy in New York City, where he graduated from the Bronx High School of Science. After graduating from Yale College (B.S., Molecular Biophysics and Biochemistry), Dr. Levy entered the Medical Scientist (MD/PhD) Training Program at New York University School of Medicine. There he earned his PhD under the mentorship of Drs. Peter Elsbach and Jerrold Weiss, characterizing neutrophil-derived antimicrobial proteins and peptides. Inspired by his wife Sharon’s example, he chose Pediatrics and completed both residency and fellowship at Boston Children’s Hospital. He is currently Professor at Harvard Medical School as well as principal investigator, staff physician in Infectious Diseases and the Director of the Precisions Vaccine Program in the Department of Pediatrics, Boston Children’s Hospital. The Precision Vaccines Program is an academic program that fosters international collaboration between academia, government, and industry for development of vaccine formulations optimized to protect vulnerable populations. Dr. Levy’s laboratory is focused on modeling vaccine-induced human immune responses in vitro using a variety of platforms including three-dimensional microphysiologic systems as well as global molecular (“OMIC”) approaches to accelerate and de-risk development of vaccines optimized for populations with distinct immune responses, including those at the extremes of age who suffer the most infections. He currently leads or co-leads multiple NIH/NIAID-supported studies, including (a) Adjuvant Discovery and Development Program contracts, leveraging high throughput screening to discover, characterize, and formulate novel small molecule adjuvants to enhance vaccine responses of vulnerable populations such as infants and older adults and (b) systems biology projects via the Human Immunology Project Consortium and the Immune Development in Early Life (IDEAL) program to define biomarkers of vaccine responsiveness, respiratory infection and asthma. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the PVP is also leveraging systems biology to study vaccine safety. Dr. Levy pursues discovery and development of vaccines against SARS-CoV-2, influenza, HIV, RSV and pertussis as well as an opioid vaccine against fentanyl overdose. Dr. Levy serves on the U.S. Food & Drug Administration (FDA) Vaccines and Related Biologic Products Advisory Committee (VRBPAC) and participated in the Emergency Use Authorization and approval of COVID vaccines. He has given two TEDx talks and has regularly appeared in major media including BBC, CNN, FoxNews, NBC Nightly News, National Geographic, The New York Times, Scientific American, USA Today and The Wall Street Journal. He lives in Cambridge, Massachusetts with his wife Dr. Sharon Levy and their three children.